{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:25:14Z","timestamp":1769833514792,"version":"3.49.0"},"reference-count":51,"publisher":"American Association for Cancer Research (AACR)","issue":"16","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>MicroRNAs (miRNA) are approximately 18 to 25 nucleotides in length and affect gene expression by silencing the translation of messenger RNAs. Because each miRNA regulates the expression of hundreds of different genes, miRNAs can function as master coordinators, efficiently regulating and coordinating multiple cellular pathways and processes. By coordinating the expression of multiple genes, miRNAs are responsible for fine-tuning the cell's most important processes, like the ones involved in cellular growth and proliferation. Dysregulation of miRNAs appears to play a fundamental role in the onset, progression and dissemination of many cancers, and replacement of downregulated miRNAs in tumor cells results in a positive therapeutic response. Thus, in theory, inhibition of a particular miRNA linked to cancer onset or progression can remove the inhibition of the translation of a therapeutic protein\u2014and conversely, administration of a miRNA mimetic can boost the endogenous miRNA population repressing the translation of an oncogenic protein. Although several basic questions about their biologic principles still remain to be answered, and despite the fact that all data with respect to miRNAs and therapy are still at the preclinical level, many specific characteristics of miRNAs in combination with compelling therapeutic efficacy data have triggered the research community to start exploring the possibilities of using miRNAs as potential therapeutic candidates. Clin Cancer Res; 18(16); 4234\u20139. \u00a92012 AACR.<\/jats:p>","DOI":"10.1158\/1078-0432.ccr-11-2010","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T02:21:42Z","timestamp":1340072502000},"page":"4234-4239","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Molecular Pathways: MicroRNAs as Cancer Therapeutics"],"prefix":"10.1158","volume":"18","author":[{"given":"Sonia A.","family":"Melo","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School; 2Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; and 3Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts"}]},{"given":"Raghu","family":"Kalluri","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School; 2Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; and 3Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts"},{"name":"Authors' Affiliations:\u20081Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School; 2Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; and 3Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts"},{"name":"Authors' Affiliations:\u20081Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School; 2Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; and 3Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts"}]}],"member":"1086","published-online":{"date-parts":[[2012,8,14]]},"reference":[{"key":"2022061021125214400_bib1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat Rev Genet"},{"key":"2022061021125214400_bib2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4161\/cc.4.9.2032","article-title":"MicroRNAs: critical regulators of development, cellular physiology and malignancy","volume":"4","author":"Mendell","year":"2005","journal-title":"Cell Cycle"},{"key":"2022061021125214400_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrg2916","article-title":"Small RNA sorting: matchmaking for Argonautes","volume":"12","author":"Czech","year":"2011","journal-title":"Nat Rev Genet"},{"key":"2022061021125214400_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"2022061021125214400_bib5","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061021125214400_bib6","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"2022061021125214400_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng.317","article-title":"A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function","volume":"41","author":"Melo","year":"2009","journal-title":"Nat Genet"},{"key":"2022061021125214400_bib8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1126\/science.1174334","article-title":"DICER1 mutations in familial pleuropulmonary blastoma","volume":"325","author":"Hill","year":"2009","journal-title":"Science"},{"key":"2022061021125214400_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ccr.2010.09.007","article-title":"A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells","volume":"18","author":"Melo","year":"2010","journal-title":"Cancer Cell"},{"key":"2022061021125214400_bib10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nbt1392","article-title":"MicroRNAs accurately identify cancer tissue origin","volume":"26","author":"Rosenfeld","year":"2008","journal-title":"Nat Biotechnol"},{"key":"2022061021125214400_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular profiles in lung cancer diagnosis and prognosis","volume":"9","author":"Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"key":"2022061021125214400_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0959-437X(02)00290-3","article-title":"RNAi: nature abhors a double-strand","volume":"12","author":"Hutv\u00e1gner","year":"2002","journal-title":"Curr Opin Genet Dev"},{"key":"2022061021125214400_bib13","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1128\/MCB.00242-06","article-title":"Mir-17\u20135p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA","volume":"26","author":"Hossain","year":"2006","journal-title":"Mol Cell Biol"},{"key":"2022061021125214400_bib14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature04303","article-title":"Silencing of microRNAs in vivo with \u2018antagomirs\u2019","volume":"438","author":"Kr\u00fctzfeldt","year":"2005","journal-title":"Nature"},{"key":"2022061021125214400_bib15","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/nar\/gkm1113","article-title":"Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver","volume":"36","author":"Elm\u00e9n","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"2022061021125214400_bib16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd3179","article-title":"Targeting microRNAs in cancer: rationale, strategies and challenges","volume":"9","author":"Garzon","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"2022061021125214400_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1618","article-title":"Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model","volume":"28","author":"Ma","year":"2010","journal-title":"Nat Biotech"},{"key":"2022061021125214400_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2009","journal-title":"Science"},{"key":"2022061021125214400_bib19","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1093\/nar\/gkn1053","article-title":"A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference","volume":"37","author":"Lu","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"2022061021125214400_bib20","first-page":"562","article-title":"Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides","volume":"2","author":"Geary","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"2022061021125214400_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0167-4781(99)00140-2","article-title":"A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides","volume":"1489","author":"Levin","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"2022061021125214400_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","article-title":"The let-7 family of microRNAs","volume":"18","author":"Roush","year":"2008","journal-title":"Trends Cell Biol"},{"key":"2022061021125214400_bib23","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/onc.2009.445","article-title":"Regression of murine lung tumors by the let-7 microRNA","volume":"29","author":"Trang","year":"2009","journal-title":"Oncogene"},{"key":"2022061021125214400_bib24","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/mt.2011.48","article-title":"Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice","volume":"19","author":"Trang","year":"2011","journal-title":"Mol. Ther"},{"key":"2022061021125214400_bib25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0006-291X(85)80140-6","article-title":"Activation of the c-K-ras oncogene in a human pancreas carcinoma","volume":"127","author":"Hirai","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"key":"2022061021125214400_bib26","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1101\/gad.1950610","article-title":"Repression of the miR-143\/145 cluster by oncogenic Ras initiates a tumor-promoting feed forward pathway","volume":"24","author":"Kent","year":"2010","journal-title":"Genes Dev"},{"key":"2022061021125214400_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1073\/pnas.81.1.71","article-title":"Isolation of transforming sequences of two human lung carcinomas: structural and functional analysis of the activated c-K-ras oncogenes","volume":"81","author":"Nakano","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061021125214400_bib28","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1158\/1535-7163.MCT-11-0152","article-title":"Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice","volume":"10","author":"Pramanik","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"2022061021125214400_bib29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature08199","article-title":"Modulation of microRNA processing by p53","volume":"460","author":"Suzuki","year":"2009","journal-title":"Nature"},{"key":"2022061021125214400_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/cdd.2009.56","article-title":"The miR-34 family in cancer and apoptosis","volume":"17","author":"Hermeking","year":"2009","journal-title":"Cell Death Differ"},{"key":"2022061021125214400_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.2284","article-title":"The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44","volume":"17","author":"Liu","year":"2011","journal-title":"Nat Med"},{"key":"2022061021125214400_bib32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.cell.2009.04.021","article-title":"Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model","volume":"137","author":"Kota","year":"2009","journal-title":"Cell"},{"key":"2022061021125214400_bib33","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1073\/pnas.0712321105","article-title":"Suppression of non-small cell lung tumor development by the let-7 microRNA family","volume":"105","author":"Kumar","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061021125214400_bib34","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1158\/0008-5472.CAN-05-3632","article-title":"Rapid alteration of microRNA levels by histone deacetylase inhibition","volume":"66","author":"Scott","year":"2006","journal-title":"Cancer Res"},{"key":"2022061021125214400_bib35","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1073\/pnas.1014720108","article-title":"The small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing","volume":"108","author":"Melo","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061021125214400_bib36","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nbt.1481","article-title":"A small molecule enhances RNA interference and promotes microRNA processing","volume":"26","author":"Shan","year":"2008","journal-title":"Nat Biotech"},{"key":"2022061021125214400_bib37","first-page":"891","article-title":"Ciprofloxacin mediated cell growth inhibition, S\/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line","volume":"6","author":"Aranha","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2022061021125214400_bib38","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2263::AID-CNCR7>3.0.CO;2-V","article-title":"The cytotoxic effect of fleroxacin and ciprofloxacin on transitional cell carcinoma in vitro","volume":"80","author":"Ebisuno","year":"1997","journal-title":"Cancer"},{"key":"2022061021125214400_bib39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjc.6600079","article-title":"Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells","volume":"86","author":"Herold","year":"2002","journal-title":"Br J Cancer"},{"key":"2022061021125214400_bib40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/1381612013398059","article-title":"The chemical and biological aspects of fluoroquinolones: reality and dreams","volume":"7","author":"Bhanot","year":"2001","journal-title":"Curr Pharm Des"},{"key":"2022061021125214400_bib41","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1016\/S0002-9343(02)01059-8","article-title":"The expanding role of fluoroquinolones","volume":"113","author":"Schaeffer","year":"2002","journal-title":"Am J Med"},{"key":"2022061021125214400_bib42","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1158\/0008-5472.CAN-10-3340","article-title":"ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2","volume":"71","author":"Jeon","year":"2011","journal-title":"Cancer Res"},{"key":"2022061021125214400_bib43","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1093\/carcin\/bgq192","article-title":"Oncogenic HER2\u039416 suppresses miR-15a\/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors","volume":"31","author":"Cittelly","year":"2010","journal-title":"Carcinogenesis"},{"key":"2022061021125214400_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1476-4598-9-317","article-title":"Downregulation of miR-342 is associated with tamoxifen resistant breast tumors","volume":"9","author":"Cittelly","year":"2010","journal-title":"Mol. Cancer"},{"key":"2022061021125214400_bib45","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-Fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"2022061021125214400_bib46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.299.4.425","article-title":"MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma","volume":"299","author":"Schetter","year":"2008","journal-title":"JAMA"},{"key":"2022061021125214400_bib47","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/sj.bjc.6605958","article-title":"MicroRNA-21 induces resistance to the anti-tumour effect of interferonalpha\/5-fluorouracil in hepatocellular carcinoma cells","volume":"103","author":"Tomimaru","year":"2010","journal-title":"Br J Cancer"},{"key":"2022061021125214400_bib48","doi-asserted-by":"crossref","first-page":"e10630","DOI":"10.1371\/journal.pone.0010630","article-title":"Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer","volume":"5","author":"Hwang","year":"2010","journal-title":"PLoS ONE"},{"key":"2022061021125214400_bib49","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/nar\/gkm024","article-title":"Specificity, duplex degradation and subcellular localization of antagomirs","volume":"35","author":"Kr\u00fctzfeldt","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"2022061021125214400_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.gene.2005.12.031","article-title":"LNA-modified oligonucleotides mediate specific inhibition of microRNA function","volume":"372","author":"\u00d8rom","year":"2006","journal-title":"Gene"},{"key":"2022061021125214400_bib51","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"}],"container-title":["Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/18\/16\/4234\/2005382\/4234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/18\/16\/4234\/2005382\/4234.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T02:19:12Z","timestamp":1654913952000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article\/18\/16\/4234\/15168\/Molecular-Pathways-MicroRNAs-as-Cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,14]]},"references-count":51,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2012,8,14]]},"published-print":{"date-parts":[[2012,8,15]]}},"URL":"https:\/\/doi.org\/10.1158\/1078-0432.ccr-11-2010","relation":{},"ISSN":["1078-0432","1557-3265"],"issn-type":[{"value":"1078-0432","type":"print"},{"value":"1557-3265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,14]]}}}